Themis Medicare share news, announcements and annual reports
NSE: THEMISMEDBSE: 530199Pharmaceuticals & BiotechnologySmall Cap
Themis Medicare Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Apr 2007 on NSE
Last close ₹94.83down ₹2.69 (2.76%)BSE ₹95.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹97.52.
30 Oct: open ₹97.39, high ₹99.58, low ₹94.02
52-week range of traded prices to 30 Oct 2026
₹64.95Low, 30 Mar 2026₹140.60High, 7 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹873 Cr1,570th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.85
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.19
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −13.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,90035.0% delivered
Themis Medicare share news and announcements
713 announcements, routine notices left out, newest first. Page 3 of 15.
Jun 2024
6 Jun · Management
May 2024
14 May · Corporate action
14 May · Dividend
14 May · Results
3 May · Dividend
Apr 2024
Mar 2024
8 Mar · Meeting
Feb 2024
29 Feb · Analysts
23 Feb · Analysts
19 Feb · Disclosure
10 Feb · Board meeting
10 Feb · Results
Jan 2024
29 Jan · Board meeting
25 Jan · Rating
Nov 2023
4 Nov · Board meeting
4 Nov · Board meeting
4 Nov · Results
Oct 2023
31 Oct · Analysts
25 Oct · Board meeting
16 Oct · Meeting
Sep 2023
26 Sep · Legal
Exchange has sought clarification from Themis Medicare Limited with respect to announcement dated 10-Aug-2023, regarding " Themis Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 10, 2023.".On basis of above the Company is required to clarify following:1. Name of the target entity, details in brief such as size, turnover etc; 2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length"; 3. Industry to which the entity being acquired belongs; 4. Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); 5. Brief details of any governmental or regulatory approvals required for the acquisition; 6. Indicative time period for completion of the acquisition; 7. Cost of acquisition or the price at which the shares are acquired; 8. Nature of consideration - whether cash consideration or share swap and details of the same; 9. Percentage of shareholding / control acquired and / or number of shares acquired; 10. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief). The response of the Company is awaited.20 Sep · Corporate action
20 Sep · Updates
Aug 2023
29 Aug · Rating
10 Aug · Board meeting
10 Aug · Results
4 Aug · Board meeting
Meeting on 10 Aug 2023: “THEMIS MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ende”2 Aug · Board meeting
Jun 2023
May 2023
13 May · Dividend
13 May · Corporate action
13 May · Corporate action